• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

威胁福利:评估人类神经精神疾病非人模型中的知识生产。

Threats to Benefits: Assessing Knowledge Production in Nonhuman Models of Human Neuropsychiatric Disorders.

出版信息

Hastings Cent Rep. 2022 Nov;52 Suppl 2(Suppl 2):S34-S40. doi: 10.1002/hast.1430.

DOI:10.1002/hast.1430
PMID:36484505
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9747248/
Abstract

Recent reports and papers on chimeric research highlight the promise of chimeric models of human neuropsychiatric disorders to ameliorate human suffering due to autism spectrum disorders, depression, and schizophrenia. These calls, however, typically do not acknowledge, much less address, criticisms of model creation and validation, or concerns about scientific conduct more generally. The ethical justification for the use of nonhuman animals in research depends on the production of benefits to humans based on such research. But the assessment and production of benefits are highly uncertain and rife with both practical and conceptual challenges. This essay provides a general framework for classifying the benefits of biomedical research and then focuses on two factors that directly impact-and threaten-the production of knowledge in research that models neuropsychiatric disorders.

摘要

近期关于嵌合研究的报告和论文强调了构建人类神经精神疾病嵌合模型的前景,这有望减轻自闭症谱系障碍、抑郁症和精神分裂症给人类带来的痛苦。然而,这些呼吁通常没有认识到,更不用说解决模型创建和验证的批评,或者更普遍的科学行为的担忧。在研究中使用非人类动物的伦理理由取决于基于此类研究为人类带来的益处。但是,益处的评估和产生具有高度的不确定性,并且存在着实际和概念上的挑战。本文提供了一个分类生物医学研究益处的一般框架,然后重点讨论了两个直接影响和威胁到模拟神经精神疾病的研究中知识产生的因素。

相似文献

1
Threats to Benefits: Assessing Knowledge Production in Nonhuman Models of Human Neuropsychiatric Disorders.威胁福利:评估人类神经精神疾病非人模型中的知识生产。
Hastings Cent Rep. 2022 Nov;52 Suppl 2(Suppl 2):S34-S40. doi: 10.1002/hast.1430.
2
Clarifying the Ethics and Oversight of Chimeric Research.阐明嵌合体研究的伦理和监督问题。
Hastings Cent Rep. 2022 Nov;52 Suppl 2(Suppl 2):S2-S23. doi: 10.1002/hast.1427.
3
Reevaluating Benefits in the Moral Justification of Animal Research: A Comment on "Necessary Conditions for Morally Responsible Animal Research".重新评估动物研究道德正当性中的益处:评《道德上负责任的动物研究的必要条件》
Camb Q Healthc Ethics. 2020 Jan;29(1):131-143. doi: 10.1017/S0963180119000860.
4
Human, Nonhuman, and Chimeric Research: Considering Old Issues with New Research.人类、非人类和嵌合体研究:用新研究审视旧问题
Hastings Cent Rep. 2022 Nov;52 Suppl 2:S29-S33. doi: 10.1002/hast.1429.
5
Right care, first time: a highly personalised and measurement-based care model to manage youth mental health.精准医疗,首次就诊:高度个性化和基于评估的青少年心理健康管理医疗模式。
Med J Aust. 2019 Nov;211 Suppl 9:S3-S46. doi: 10.5694/mja2.50383.
6
Culture of Care: Organizational Responsibilities关怀文化:组织职责
7
Ethical acceptability of research on human-animal chimeric embryos: summary of opinions by the Japanese Expert Panel on Bioethics.人兽嵌合胚胎研究的伦理可接受性:日本生物伦理专家小组意见摘要
Life Sci Soc Policy. 2015;11:15. doi: 10.1186/s40504-015-0033-z. Epub 2015 Dec 22.
8
Moral Status and the Oversight of Research Involving Chimeric Animals.道德地位与涉及嵌合体动物的研究监督
Hastings Cent Rep. 2022 Nov;52 Suppl 2:S41-S45. doi: 10.1002/hast.1431.
9
Risk management frameworks for human health and environmental risks.人类健康与环境风险的风险管理框架。
J Toxicol Environ Health B Crit Rev. 2003 Nov-Dec;6(6):569-720. doi: 10.1080/10937400390208608.
10
Nonhuman primate models of neuropsychiatric disorders: influences of early rearing, genetics, and epigenetics.神经精神疾病的非人灵长类动物模型:早期饲养、遗传学和表观遗传学的影响
ILAR J. 2014;55(2):361-70. doi: 10.1093/ilar/ilu025.

引用本文的文献

1
From Serendipity to Precision: Integrating AI, Multi-Omics, and Human-Specific Models for Personalized Neuropsychiatric Care.从意外发现到精准医疗:整合人工智能、多组学和人类特异性模型以实现个性化神经精神疾病护理。
Biomedicines. 2025 Jan 12;13(1):167. doi: 10.3390/biomedicines13010167.

本文引用的文献

1
Plaque-associated human microglia accumulate lipid droplets in a chimeric model of Alzheimer's disease.斑块相关的人类小胶质细胞在阿尔茨海默病的嵌合模型中积累脂滴。
Mol Neurodegener. 2021 Jul 23;16(1):50. doi: 10.1186/s13024-021-00473-0.
2
In Vivo Chimeric Alzheimer's Disease Modeling of Apolipoprotein E4 Toxicity in Human Neurons.在体嵌合阿尔茨海默病模型中人载脂蛋白 E4 毒性的研究。
Cell Rep. 2020 Jul 28;32(4):107962. doi: 10.1016/j.celrep.2020.107962.
3
The ARRIVE guidelines 2.0: Updated guidelines for reporting animal research.ARRIVE 指南 2.0:报告动物研究的更新指南。
PLoS Biol. 2020 Jul 14;18(7):e3000410. doi: 10.1371/journal.pbio.3000410. eCollection 2020 Jul.
4
Can Knowledge Itself Justify Harmful Research?知识本身能为有害研究辩护吗?
Camb Q Healthc Ethics. 2020 Apr;29(2):302-307. doi: 10.1017/S0963180119001087.
5
Joining forces: the need to combine science and ethics to address problems of validity and translation in neuropsychiatry research using animal models.联合力量:使用动物模型进行神经精神医学研究时,需要将科学和伦理学结合起来解决有效性和转化问题。
Philos Ethics Humanit Med. 2020 Jan 23;15(1):1. doi: 10.1186/s13010-019-0085-4.
6
Modeling neurological disease using human stem cell-derived microglia-like cells transplanted into rodent brains.利用移植到啮齿动物大脑中的人类干细胞衍生的小胶质细胞样细胞对神经疾病进行建模。
Lab Anim (NY). 2020 Feb;49(2):49-51. doi: 10.1038/s41684-019-0465-9.
7
Reevaluating Benefits in the Moral Justification of Animal Research: A Comment on "Necessary Conditions for Morally Responsible Animal Research".重新评估动物研究道德正当性中的益处:评《道德上负责任的动物研究的必要条件》
Camb Q Healthc Ethics. 2020 Jan;29(1):131-143. doi: 10.1017/S0963180119000860.
8
Beyond the 3 Rs to a More Comprehensive Framework of Principles for Animal Research Ethics.超越 3R 原则,迈向更全面的动物研究伦理原则框架。
ILAR J. 2021 Sep 24;60(3):308-317. doi: 10.1093/ilar/ilz011.
9
Development of a Chimeric Model to Study and Manipulate Human Microglia In Vivo.体内研究和操纵人类小胶质细胞的嵌合模型的开发。
Neuron. 2019 Sep 25;103(6):1016-1033.e10. doi: 10.1016/j.neuron.2019.07.002. Epub 2019 Jul 30.
10
Human-Monkey Chimeras for Modeling Human Disease: Opportunities and Challenges.人类-猴嵌合体用于模拟人类疾病:机遇与挑战。
Stem Cells Dev. 2018 Dec 1;27(23):1599-1604. doi: 10.1089/scd.2018.0162.